BATCH OF 20 SAYPHA VOLUME LIDO (1x1ml) CROMA

SAYPHA VOLUME LIDO (1x1ml) CROMA

MEDICAL USE. CE Marked Medical Device class III. SMART - a unique method of cross–linking created by CROMA.

DESCRIPTION

SAYPHA VOLUME LIDOCAINE is a highly cross-linked, sterile,viscoelastic, biodegradable, monophasic hyaluronic acid gel filler which is best used to correct deep wrinkles, folds and scarring, for facial contouring and building volume. SAYPHA VOLUME LIDOCAINE is a clear, colourless, isotonic and homogenized injectable gel implanted is injected in the deep dermis with a 27G1/2 needle. It consists of cross-linked hyaluronic acid, formulated to a concentration of 23 mg/ml in a physiologic buffer. TECHNOLOGY S. M. A. R. T.

SAYPHA VOLUME LIDOCAINE by CROMA DETAILS

• Concentration HA : 2.3 % (23 mg/mL)
• Lidocaine :  0,3%
• Reticulating agent : BDDE 3/4
• Other ingredients : Phosphate-buffer, NaCI
• Dynamic viscosity (at shear rate 2 s-1: ) : 90.000 – 135.000 mPa.s.
• Needle: 2 x 27G 1⁄2 thin-wall needles.
• Packaging : Box of 1 mL syringe
• Injection area : Deep dermis or subcutis.
• Indication : Viscoelastic solution for the correction of deep wrinkles and folds, to increase or restore facial volume, and to shape the facial contours.
• Estimated duration in the skin: At least 9 months.

PACKAGING

• 1 x 1ml : Box of 1 ml pre-filled syringe.
• Needles : 2 X 27 G1/2 thin wall Terumo needles ( CE 0197).
• Two traceability labels.

INDICATION

VOLUMISING ACTION. SAYPHA VOLUME is indicated for the correction of deep wrinkles and folds, cutaneous depressions, facial contours and the creation of volume. Deep and volumetric treatments. Viscoelastic solution for the correction of deep wrinkles and folds, to increase facial volume, and to shape and remodel the facial contours. To adress reconstructive purposes in the treatment of facial lipoatrophy, debilitating scars or morphological asymetry.

COMPOSITION

Cross-linked degree 3/4 Hyaluronic acid BDDE 2.3 % (23 mg/mL) + Lidocaine 0,3% :

• It consists of cross-linked hyaluronic acid, formulated to a concentration of 23 mg/ml in a physiologic buffer.
• Level of cross-linking 3/4.
• Cross-linking agent : BDDE (14%).
• Lidocaine 0,3%.
• OPTIMAL SKIN-TOLERANCE by use of non-animal hyaluronic acid.

INJECTION DEPTH

Injected in the deep dermis or subcutis.

DURATION

9 months.

INJECTION AREA

• Volume of cheekbones.
• Nasolabial fold.
• Wrinkles of the puppet.
• Chin.
• Facial depressive.

RESULTS

TREATMENT SATISFACTION nearly 98% patients are satisfied with our products. IMMEDIATELY VISIBLE effectively after your treatment you see the result. LONG-LASTING RESULTS by formulation which shows an effect of severeal months.